Takeda stem cell facility puts Irish pharma at cutting edge of modern medicine
Interview: Thomas Wozniewski, head of global manufacturing and supply at Takeda
Stay updated with breaking news from Alofisel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Interview: Thomas Wozniewski, head of global manufacturing and supply at Takeda
Grange Castle site will supply Crohn’s therapy to patients in Europe, the US and Canada
TOKYO (dpa-AFX) - Takeda Pharmaceutical Co. Ltd. (TAK), said on Friday that clinical remission was observed in 65% of patients with Crohn's disease and complex perianal fistulas in a phase III
Takeda Pharmaceutical Company Limited Takeda Submits New Drug Application to Manufacture and Market Darvadstrocel In Japan for Treatment of Complex Perianal Fistulas in Adult Patients with Crohn's Disease Wednesday, February 10, 2021 12:15PM IST (6:45AM GMT) Takeda Applies for Approval for the Company’s First Allogeneic Stem Cell Therapy in Japan If Approved, Darvadstrocel Would Offer a Potential Cell-Mediated Closure Option for Adult Patients in Japan Who Do Not Respond to Conventional or Biologic Therapies for Complex Perianal Fistulas in Crohn’s Disease 1,2 Takeda Pharmaceutical Com...